Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

in HemaSphere by Kai Hübel, Mark Bower, Igor Aurer, Mariana Bastos-Oreiro, Caroline Besson, Uta Brunnberg, Chiara Cattaneo, Simon Collins, Kate Cwynarski, Alessia D Pria, Marcus Hentrich, Christian Hoffmann, Marie J Kersten, Silvia Montoto, Jose-Tomas Navarro, Eric Oksenhendler, Alessandro Re, Josep-Maria Ribera, Philipp Schommers, Bastian von Tresckow, Christian Buske, Martin Dreyling, Andy Davies,

TLDR

  • The EHA-ESMO Clinical Practice Guideline is a set of recommendations for healthcare professionals to help manage HIV-associated lymphomas. It covers different aspects of managing these diseases, such as diagnosis, treatment, and follow-up. The guideline is based on scientific data and expert opinion, and it emphasizes the importance of individualized treatment plans.

Abstract

This EHA-ESMO Clinical Practice Guideline provides key recommendations for managing HIV-associated lymphomas.The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up.The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.Recommendations are based on available scientific data and the authors' collective expert opinion.

Overview

  • The EHA-ESMO Clinical Practice Guideline provides recommendations for managing HIV-associated lymphomas. The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up. The author group is a multidisciplinary group of experts from different institutions and countries in Europe. Recommendations are based on available scientific data and expert opinion.

Comparative Analysis & Findings

  • The guideline does not provide a direct comparative analysis of different interventions or treatments. However, it does discuss the various treatment options available for HIV-associated lymphomas, including chemotherapy, immunotherapy, and combination therapies. The guideline also highlights the importance of individualized treatment plans based on the patient's specific characteristics and disease stage.

Implications and Future Directions

  • The EHA-ESMO Clinical Practice Guideline is a valuable resource for healthcare professionals managing HIV-associated lymphomas. The guideline's recommendations can help improve patient outcomes and reduce healthcare costs. Future research should focus on developing more effective and targeted treatments for HIV-associated lymphomas, as well as improving diagnostic tools and imaging techniques to better identify and stage the disease.
Read Full Article